Do chemokine ( C-C motif ) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals?
These data show that the majority of viruses in these dual/mixed-tropic populations use CCR5 and suggest that antiretroviral-naive patients may benefit from combination therapy that includes CCR5 entry inhibitors.
BRCAness identified by MLPA was practically useful for treatment selection for avoiding taxane. ALDH1 may be considered as a marker for the CSC subtype requiring novel agents.